CLINICAL_TRIALS
trial_result
· 2019-10-29
Clinical Trial Update: Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein [Phase 3]
Summary
A Phase 3 trial evaluating TheraSphere for inoperable liver cancer with portal vein blockage was terminated with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: TERMINATED | Results posted: 2019-10-29